NPPB and endothelial dysfunction: Thus, it could be speculated that in our study, the reduction in NTproBNP levels observed in patients treated with DOACs at follow-up could be potentially related to anti-inflammatory effects and the amelioration of endothelial dysfunction mediated by DOACs.